Please login to the form below
Vaccibody name Martin Bonde as CEO
He joins from EpiTherapeutics where he holds the same role
Norwegian cancer vaccine company Vaccibody has appointed Dr Martin Bonde as CEO, effective from August 10.
Bonde has over 25 years of international experience in the biotech industry, starting his career at Dako and going on to work at companies including Ostemeter, Visiopharm and Aros Pharma.
He joins from EpiTherapeutics, where he has held the role of CEO since 2009.
Tom Pike, chairman of Vaccibody, said: "We are delighted to welcome Martin Bonde to Vaccibody. The Vaccibody technology has a wide business development potential within many market segments, which will benefit greatly from Martin's extensive track record in deal making.
“We also believe that our ability to attract an experienced industry executive with Martin's credentials reflect positively on Vaccibody's' considerable potential”.
Bonde's experience in the sector includes a number of transactions within business development, trade sales, mergers and acquisitions and management of research and development.
COVID-19 Updates and Daily News
Featured jobs
-
Account Manager
-
£Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director
-
£Competitive Salary
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Account Director – UK Office
-
Excellent salary and benefits
-
Senior Medical Writer
-
Salary TBC
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Director, Medical Education
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Account Manager
-
Salary TBC
- WHO partners with WhatsApp to provide accurate COVID-19 information
- UPDATED: Gilead drops remdesivir’s orphan drug designation
- FDA approves Roche’s Actemra COVID-19 trial
- Takeda begins development of COVID-19 plasma therapy
- UK, China prep trials of coronavirus vaccine candidates
- Did Trump offer CureVac $1bn for COVID-19 vaccine rights?
- COVID-19 delays Pfizer, Mylan’s generics merger and spin-out
- UK contributes £210m towards COVID-19 vaccine efforts
- Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19
- In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
- COVID-19 message to clients from OPEN Health CEO, David Rowley
- The march to sustainability
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- The role of women in science and technology
- Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
- China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
- China secures a place at the forefront of innovative medicine...
- Virtual Research Grants Submission and Approval Program
- Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....
Quick links
Infographics
